PCM
ADVM

Pinz Capital Management’s Adverum Biotechnologies ADVM Stock Holding History

Pinz Capital Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$15K Buy
+1,570
New +$20.6K 0.03% 98
2021
Q4 		– Sell
-5,360
Closed -$116K – 371
2021
Q3 		$116K Buy
+5,360
New +$137K 0.05% 110

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pinz Capital Management's ADVM Position: Q3 2022 in Review

Pinz Capital Management opened a new position in Adverum Biotechnologies (ADVM) in Q3 2022: 1,570 shares worth $15K. The stake represents 0.03% of the portfolio and ranks #98 among its holdings. This is a return to the name: Pinz Capital Management previously reported a position in ADVM as recently as Q3 2021.

Pinz Capital Management first reported a position in ADVM in Q3 2021 and has held it in 2 quarters since. The position peaked at $116K in Q3 2021. 78 funds tracked by Wall St. Rank hold ADVM as of Q3 2022.

  • Pinz Capital Management held 1,570 shares of Adverum Biotechnologies worth $15K as of Q3 2022.
  • Adverum Biotechnologies was a new Pinz Capital Management position in Q3 2022.
  • Adverum Biotechnologies made up 0.03% of Pinz Capital Management's portfolio in Q3 2022, its #98 holding.
  • Pinz Capital Management first reported a position in Adverum Biotechnologies in Q3 2021 and has held it in 2 quarters since.
  • Pinz Capital Management's Adverum Biotechnologies position peaked at $116K in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2022.

Based on Pinz Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.